<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0131374</article-id>
<article-id pub-id-type="publisher-id">PONE-D-14-34952</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">HLA-DQB1 Polymorphisms and Risk for GBS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Jin</surname>
<given-names>Peng-Peng</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Sun</surname>
<given-names>Li-Li</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Ding</surname>
<given-names>Bo-Jun</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Qin</surname>
<given-names>Na</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhou</surname>
<given-names>Bin</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xia</surname>
<given-names>Feng</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Li</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Li-Juan</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Xue-Dong</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhao</surname>
<given-names>Gang</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Wen</given-names>
</name>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Deng</surname>
<given-names>Yan-Chun</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Hou</surname>
<given-names>Shuang-Xing</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Centre for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai 201399, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Unit of Evidence-Based Medicine, K. K. Leung Brain Research Centre, Fourth Military Medical University, Xi’an 710032, China</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Neurology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai 201399, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Linker</surname>
<given-names>Ralf Andreas</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Friedrich-Alexander University Erlangen, GERMANY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: SXH. Performed the experiments: PPJ LLS BJD NQ. Analyzed the data: PPJ LLS BJD. Contributed reagents/materials/analysis tools: BZ FX LL LJL XDL GZ WW YCD. Wrote the manuscript: PPJ SXH.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">housx120@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>7</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>7</issue>
<elocation-id>e0131374</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>1</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>6</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Jin et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0131374" xlink:type="simple"/>
<abstract>
<p>Guillain-Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system. There is no consensus regarding reported associations between human leukocyte antigen DQB1 (HLA-DQB1) polymorphisms and the risk for developing GBS. Here, we evaluated possible associations between HLA-DQB1 polymorphisms and the risk for GBS using a meta-analysis. We searched PubMed for case-control genetic association studies for HLA-DQB1 polymorphisms (*020x, *030x, *040x, *050x, and *060x) and the risk for GBS. Fixed-effect meta-analytical methods were used for the outcome measure and subgroup analyses. Estimated odds ratios (ORs) and 95% confidence intervals (CIs) were used to investigate the associations between HLA-DQB1 polymorphisms and the risk for GBS. Nine case-control studies involving 780 cases of GBS and 1353 controls were identified in the current study. The meta-analysis demonstrated no significant associations between HLA-DQB1 polymorphisms and the risk for GBS in Asian and Caucasian populations. There were two associations that approached significance: HLA-DQB1*030x in Asian patients (<italic>P</italic> = 0.07; OR: 0.76, 95% CI: 0.57–1.03) and HLA-DQB1*060x in all patients (<italic>P</italic> = 0.08; OR: 1.48, 95% CI: 0.96–2.29). Additional studies with larger sample sizes are required to establish a definitive assessment of the contribution of HLA-DQB1 polymorphisms to GBS risk.</p>
</abstract>
<funding-group>
<funding-statement>This study was supported by grants from the Natural Science Foundation of China (No. 31070976, 81172291, and 81030010), intramural funds of the Fourth Military Medical University (China, 2012), and the Key Science and Technology Program of Shaanxi Province, China (2011 SK11-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="2"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Guillain-Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system. GBS is initiated by an abnormal response to an infectious pathogen and is characterized by progressive flaccid paralysis and loss of reflexes. GBS is a heterogeneous disorder with several subtypes, including acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), and acute motor sensory axonal neuropathy (AMSAN) [<xref rid="pone.0131374.ref001" ref-type="bibr">1</xref>]. The prevalence of the subtypes varies regionally; AIDP is the most common subtype in the West, while AMAN and AMSAN are more common in Asia [<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>]. Infections including Cytomegalovirus, Epstein-Barr virus, and <italic>Campylobacter jejuni</italic> have all been linked to GBS [<xref rid="pone.0131374.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>]. <italic>C</italic>. <italic>jejuni</italic> infection is the most common infectious trigger and is present in 25–40% of GBS cases [<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>]. However, the annual incidence of GBS is very small, 0.6–4 cases per 100,000 population, which equates to approximately 1 out of every 1,000–5,000 cases of <italic>C</italic>. <italic>jejuni</italic> infection [<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0131374.ref003" ref-type="bibr">3</xref>]. The rarity of GBS cases, even in patients with <italic>C</italic>. <italic>jejuni</italic>, suggests that other factors determine whether a patient will develop GBS following infection.</p>
<p>A candidate risk factor for host susceptibility to GBS is the human leukocyte antigen (HLA) haplotype. HLAs are highly polymorphic gene clusters that affect immune responses to infection [<xref rid="pone.0131374.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0131374.ref006" ref-type="bibr">6</xref>] and are implicated in autoimmune diseases [<xref rid="pone.0131374.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0131374.ref008" ref-type="bibr">8</xref>]. While associations with major histocompatibility complex (MHC) class I antigens have been documented, these are often secondary to associations with MHC class II antigens [<xref rid="pone.0131374.ref009" ref-type="bibr">9</xref>]. HLA class II molecules play an important role in activating immune responses and help recognize self or foreign antigens [<xref rid="pone.0131374.ref010" ref-type="bibr">10</xref>]. The HLA class II genes, especially the highly polymorphic HLA-DQ alleles, may mediate the autoimmune responses that contribute to GBS [Klein 2000].</p>
<p>Several reports have described the relationship between class II HLA-DQ polymorphisms and the risk for various autoimmune diseases, including GBS [<xref rid="pone.0131374.ref011" ref-type="bibr">11</xref>]. Associations between the HLA-DQB1*03 and HLA-DQB1*060x polymorphisms and the risk for GBS have been investigated previously in patients of different ethnicities. In patients from northern China, HLA alleles are differentially distributed in two forms of GBS (AIDP and AMAN) [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>]. In Caucasian GBS patients, an association between the HLA-DQB1*03 polymorphism and <italic>C</italic>. <italic>jejuni</italic> infection has been reported [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>]; and in Indian patients, the HLA-DQB1*060x polymorphism has been associated with risk for GBS [<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>]. However, to date, there is no consensus regarding whether GBS is linked to HLA type. Previous work has been limited by small sample sizes, imprecise HLA typing by current standards, and ethnic and geographical differences across studies. The objective of this meta-analysis was to evaluate the relationship between HLA-DQB1 polymorphisms and the risk for GBS based on currently available case-control studies.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>This meta-analysis was performed following the Quality of Reporting of Meta-analyses (QUORUM) guidelines [<xref rid="pone.0131374.ref015" ref-type="bibr">15</xref>] and the recommendations of the Cochrane Collaboration [<xref rid="pone.0131374.ref016" ref-type="bibr">16</xref>].</p>
<sec id="sec003">
<title>Search strategy</title>
<p>We conducted a systematic search of PubMed (1950–December, 2014) using the following key words: “Human leukocyte antigen*” OR “HLA*” AND “allele” OR “polymorphism” OR “genotype” AND “Guillain-Barré syndrome” OR “acute infiammatory demyelinating polyneuropathy” OR “acute motor axonal neuropathy” OR “acute motor sensory axonal neuropathy.” Additional information was retrieved by a hand search of the reference lists of relevant articles. We repeated the search using the terms “DQB1*01”, “DQB1*02”, “DQB1*03”, “DQB1*04”, “DQB1*05”, and “DQB1*06” in place of the more general terms HLA or human leukocyte antigen. No additional unique records were identified, so we proceeded using only the search results from our original query.</p>
</sec>
<sec id="sec004">
<title>Inclusion and exclusion criteria</title>
<p>We included studies that (1) examined the potential association between HLA polymorphisms and the risk for GBS; (2) had a case-control design; (3) selected controls from healthy people or the community; and (4) contained sufficient information on genotype frequency. To achieve statistical power, we only considered polymorphisms that were reported in more than two publications. Our search was limited to articles written in English.</p>
<p>We excluded publications that (1) were reviews, editorials, or comments; (2) did not evaluate the association between HLA polymorphisms and the risk for GBS; (3) did not report genotype frequency or the relevant information could not be obtained by contacting the study authors; (4) reported on polymorphisms that were examined in less than two publications; (5) were duplicate studies; or (6) were basic science or animal studies.</p>
</sec>
<sec id="sec005">
<title>Study selection</title>
<p>Three review authors (SX Hou, LL Sun, and PP Jin) independently examined the titles and abstracts to select eligible studies. We retrieved the full-text articles of potentially relevant studies. Where data sets were overlapping or duplicated, only the most recent information and the largest study size were included. Three review authors (SX Hou, LL Sun, and PP Jin) independently examined the full-text records to determine which studies met the inclusion criteria. Disagreements regarding study selection were resolved through group discussion and consensus.</p>
</sec>
<sec id="sec006">
<title>Data extraction</title>
<p>Four review authors (SX Hou, LL Sun, JB Dong, and LJ Liu) independently extracted information from eligible studies. Data included the following: first author’s name, year of publication, patient population, number of cases and controls, genotyping protocols, and diagnostic criteria. The final analysis included event counts from cases and controls for allele typing out to two digits, where necessary, derived from more extensive typing. Disagreements regarding data extraction were resolved through group discussion and consensus.</p>
</sec>
<sec id="sec007">
<title>Subgroup analyses</title>
<p>Subgroup analyses were performed by stratifying patients according to ethnicity (Asian and Caucasian). One full-text study [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>] was excluded from the subgroup analyses as the participants were neither Asian nor Caucasian.</p>
</sec>
<sec id="sec008">
<title>Statistical methods</title>
<p>Statistical analyses were conducted using Review Manager 5.1 software (Cochrane Collaboration, <ext-link ext-link-type="uri" xlink:href="http://ims.cochrane.org/revman/download" xlink:type="simple">http://ims.cochrane.org/revman/download</ext-link>). Odds ratios (ORs) and their 95% confidence intervals (95% CIs) were used to estimate the strengths of the associations between HLA polymorphisms and the risk for GBS. The Z test determined the significance of the pooled OR, and a P value less than 0.05 was considered significant. A random-effects model was used to pool studies with significant heterogeneity (Der Simonian and Laird method [<xref rid="pone.0131374.ref018" ref-type="bibr">18</xref>]) as determined by Cochran’s χ<sup>2</sup>-based Q statistic test (<italic>P</italic> ≤ 0.10) [<xref rid="pone.0131374.ref019" ref-type="bibr">19</xref>] and the inconsistency index (<italic>I</italic><sup><italic>2</italic></sup> ≥ 50%) [<xref rid="pone.0131374.ref020" ref-type="bibr">20</xref>]. Otherwise, a fixed-effects model (Mantel-Haenszel method [<xref rid="pone.0131374.ref021" ref-type="bibr">21</xref>]) was used to calculate the pooled ORs and P values.</p>
<p>Publication bias was assessed using a funnel plot of effect estimates against their standard errors (SEs), Begg-Mazumdar rank correlation, and Egger’s test [<xref rid="pone.0131374.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0131374.ref023" ref-type="bibr">23</xref>].</p>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<p>The searches identified 184 articles, of which 80 were unique records and 71 were in English. Based on screening the titles and abstracts, 30 studies were identified as potentially eligible for inclusion. After analyzing the full-text articles, 21 studies were excluded and nine [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>] were found eligible for inclusion according to our criteria for this review (<xref rid="pone.0131374.g001" ref-type="fig">Fig 1</xref>).</p>
<fig id="pone.0131374.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow chart of article screening and selection process.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g001" position="float" xlink:type="simple"/>
</fig>
<sec id="sec010">
<title>Included studies</title>
<p>The characteristics of the included studies are shown in <xref rid="pone.0131374.t001" ref-type="table">Table 1</xref>. Of these studies, five [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>] were conducted in Asian populations, three were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0131374.ref027" ref-type="bibr">27</xref>], and one was conducted in an Arabic population [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>]. All of the studies were population-based, and the controls were selected from healthy subjects.</p>
<table-wrap id="pone.0131374.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.t001</object-id>
<label>Table 1</label> <caption><title>Included Study Characteristics.</title></caption>
<alternatives>
<graphic id="pone.0131374.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Study (Author, year)</th>
<th align="left" rowspan="1" colspan="1">Methods</th>
<th align="left" rowspan="1" colspan="1">Participants</th>
<th align="left" rowspan="1" colspan="1">Outcomes</th>
<th align="left" rowspan="1" colspan="1">Ethnicity</th>
<th align="left" rowspan="1" colspan="1">Country</th>
<th align="left" rowspan="1" colspan="1">Diagnostic Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Rees 1997<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref></td>
<td align="left" rowspan="1" colspan="1">DNA was extracted from peripheral blood and the DQB1 alleles were identified by PCR.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 97; Healthy Controls = 100</td>
<td align="left" rowspan="1" colspan="1">DQB1*020x DQB1*030x DQB1*040x DQB1*050x DQB1*0601</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">England/Wales</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Koga 1998</td>
<td align="left" rowspan="1" colspan="1">DQB1 alleles were typed using the PCR-dependent preferential heteroduplex formation assay.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 35; Healthy Controls = 112</td>
<td align="left" rowspan="1" colspan="1">DQB1*020x DQB1*030x DQB1*040x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ma 1998</td>
<td align="left" rowspan="1" colspan="1">HLA-DQB1 allele typing was performed using a modified PCR-restriction fragment length polymorphism method combined with group-specific primers.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 81; Healthy Controls = 87</td>
<td align="left" rowspan="1" colspan="1">DQB1*030x DQB1; 040x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Li 2000</td>
<td align="left" rowspan="1" colspan="1">DNA was extracted from white blood cells and the HLA typing was performed using PCR with sequence-specific primers.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 47; Healthy Controls = 50</td>
<td align="left" rowspan="1" colspan="1">DQB1*020x DQB1*030x DQB1*040x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Magira 2003<xref rid="t001fn002" ref-type="table-fn"><sup>b</sup></xref></td>
<td align="left" rowspan="1" colspan="1">Genomic DNA was obtained and HLA typing performed by PCR with sequence-specific primers.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 72 (47 AMAN, 25 AIDP); Healthy Controls = 97</td>
<td align="left" rowspan="1" colspan="1">DQB1*020x DQB1*030x DQB1*040x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Geleijns 2005</td>
<td align="left" rowspan="1" colspan="1">Genomic DNA was extracted from whole blood samples and the HLA type was determined at the two-digit level using PCR with sequence-specific primers.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 164; Healthy Controls = 207</td>
<td align="left" rowspan="1" colspan="1">DQB1*02 DQB1*03 DQB1*04 DQB1*05 DQB1*06</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Netherlands</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">McCombe 2006</td>
<td align="left" rowspan="1" colspan="1">Genomic DNA was extracted from whole blood and the HLA-DQB alleles were typed using Dynal low-resolution SSP kits.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 74; Healthy Controls = 158</td>
<td align="left" rowspan="1" colspan="1">DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Caucasian (n = 73) and Asian (n = 1)</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sinha 2010<xref rid="t001fn003" ref-type="table-fn"><sup>c</sup></xref></td>
<td align="left" rowspan="1" colspan="1">Genomic DNA was isolated from whole blood and the HLA type at the HLA-II DQB1 locus was determined at the two-digit level using PCR with sequence-specific primers.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 54; Healthy Controls = 202</td>
<td align="left" rowspan="1" colspan="1">DQB1*0201 DQB1*030x DQB1*040x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath; subtype diagnosis based on Hadden <italic>et al</italic>.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fekih-Mrissa 2014</td>
<td align="left" rowspan="1" colspan="1">Genomic DNA was extracted from peripheral blood samples, and low-resolution HLA typing was performed using Micro SSP DNA typing trays DRB/DQB.</td>
<td align="left" rowspan="1" colspan="1">GBS cases = 38; Healthy Controls = 100</td>
<td align="left" rowspan="1" colspan="1">DQB1*020x DQB1*030x DQB1*050x DQB1*060x</td>
<td align="left" rowspan="1" colspan="1">Arabic</td>
<td align="left" rowspan="1" colspan="1">Tunisia</td>
<td align="left" rowspan="1" colspan="1">Asbury and Cornblath</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>a</sup> Blood samples were obtained from 103 GBS cases for a previous study, but only 93 were available for the analyses in this study. An additional four cases were recruited between the end of the first study and the analysis for this study.</p></fn>
<fn id="t001fn002"><p><sup>b</sup> All participants were diagnosed with GBS; however, for this study they were divided into the AMAN and AIDP forms of GBS.</p></fn>
<fn id="t001fn003"><p><sup>c</sup> HLA typing was performed on a subset of randomly selected GBS cases from a larger cohort (n = 80) and compared to a pool of 202 healthy controls rather than the pool of 80 matched healthy controls recruited for the case/control section of the study.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Data pertaining to the frequency of HLA-DQB1 alleles to at least two digits in GBS patients and healthy controls were available for-DQB1*020x,-DQB1*030x,-DQB1*040x,-DQB1*050x, and-DQB1*060x. Six studies with 448 cases and 818 controls included relevant data for the–DQB1*020x polymorphism [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Eight studies with 680 cases and 1009 controls included data for the–DQB1*030x polymorphism [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Seven studies with 598 cases and 953 controls contained data for the–DQB1*040x polymorphism [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Nine studies with 780 cases and 1353 controls included data for the–DQB1*050x and–DQB1*060x polymorphisms [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>].</p>
</sec>
<sec id="sec011">
<title>Excluded studies</title>
<p>Of the 30 studies that were relevant to HLA polymorphisms and the risk for GBS, 21 were excluded (<xref rid="pone.0131374.t002" ref-type="table">Table 2</xref>). Of these studies, 13 were excluded because the HLA typing was insufficiently precise, six were excluded because of insufficient data due to a low patient number (five were family pairs), and one was excluded because it was an animal study.</p>
<table-wrap id="pone.0131374.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.t002</object-id>
<label>Table 2</label> <caption><title>Excluded Studies.</title></caption>
<alternatives>
<graphic id="pone.0131374.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Study (Author, year)</th>
<th align="left" rowspan="1" colspan="1">Citation</th>
<th align="left" rowspan="1" colspan="1">Reason(s) for Exclusion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Adams 1977</td>
<td align="left" rowspan="1" colspan="1">Lancet. 1977 Sep 3;2(8036):504–5.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient<xref rid="t002fn001" ref-type="table-fn"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Stewart 1978</td>
<td align="left" rowspan="1" colspan="1">Ann Neurol. 1978 Sep;4(3):285–9.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Latovitzki 1979</td>
<td align="left" rowspan="1" colspan="1">Neurology. 1979 May;29(5):743–5.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient and study design was not case-control</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gorodezky 1983</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 1983 Feb;4(1):1–7.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient and included only HLA-DR alleles</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kaslow 1984</td>
<td align="left" rowspan="1" colspan="1">Neurology. 1984 Feb;34(2):240–2.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient and included only HLA-A,-B, and-C alleles</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hafez 1985</td>
<td align="left" rowspan="1" colspan="1">J Neurogenet. 1985 Sep;2(4):285–90.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Winer 1988</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 1988 Apr;18(1):13–6.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hillert 1991</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 1991 Jan;31(1):67–72.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yuki 1992</td>
<td align="left" rowspan="1" colspan="1">Muscle Nerve. 1992 Aug;15(8):968–9.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient and study design was not case-control</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Davidson 1992</td>
<td align="left" rowspan="1" colspan="1">J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):508–9.</td>
<td align="left" rowspan="1" colspan="1">Familial study with insufficient genetic data</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Piradov 1995</td>
<td align="left" rowspan="1" colspan="1">Neurology. 1995 Jul;45(7):1419–20.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient and included only HLA-DR1 and-DR6 alleles</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chiba 1995</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 1995 Aug;61(1):85–8.</td>
<td align="left" rowspan="1" colspan="1">HLA typing was insufficient</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Monos 1997</td>
<td align="left" rowspan="1" colspan="1">J Infect Dis. 1997 Dec;176 Suppl 2:S180-2.</td>
<td align="left" rowspan="1" colspan="1">Only HLA-DR alleles were characterized</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Grigg 1998</td>
<td align="left" rowspan="1" colspan="1">J Clin Neurosci. 1998 Apr;5(2):169–71.</td>
<td align="left" rowspan="1" colspan="1">Insufficient genetic data<xref rid="t002fn002" ref-type="table-fn"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wilmshurst 1999</td>
<td align="left" rowspan="1" colspan="1">Eur J Neurol. 1999 Jul;6(4):499–503.</td>
<td align="left" rowspan="1" colspan="1">Familial study with insufficient genetic data</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ang 2000</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 2000 Nov 1;111(1–2):229–33.</td>
<td align="left" rowspan="1" colspan="1">Familial study with insufficient genetic data</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">de Graaf 2004</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 2004 Oct;155(1–2):73–84.</td>
<td align="left" rowspan="1" colspan="1">Animal Study</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Senanayake 2010</td>
<td align="left" rowspan="1" colspan="1">Ceylon Med J. 2010 Dec;55(4):135–6.</td>
<td align="left" rowspan="1" colspan="1">Familial study with insufficient genetic data</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Barzegar 2012</td>
<td align="left" rowspan="1" colspan="1">Ann Indian Acad Neurol. 2012 Oct;15(4):299–302. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/0972-2327.104341" xlink:type="simple">10.4103/0972-2327.104341</ext-link>.</td>
<td align="left" rowspan="1" colspan="1">Familial study with insufficient genetic data</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Blum 2013</td>
<td align="left" rowspan="1" colspan="1">J Neuroimmunol. 2014 Feb 15;267(1–2):92–6. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jneuroim.2013.12.007" xlink:type="simple">10.1016/j.jneuroim.2013.12.007</ext-link>. Epub 2013 Dec 12.</td>
<td align="left" rowspan="1" colspan="1">Only HLA-A,-B, and-C alleles were typed</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hasan 2014</td>
<td align="left" rowspan="1" colspan="1">Neurosciences (Riyadh). 2014 Oct;19(4):301–5.</td>
<td align="left" rowspan="1" colspan="1">Only HLA-DR alleles were characterized</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p><sup>a</sup> Insufficient HLA typing was considered for any analysis that was not able to identify the HLA allele to at least two digits.</p></fn>
<fn id="t002fn002"><p><sup>b</sup> Studies with insufficient genetic data included only 2–3 GBS cases, were usually family groupings, and did not have a case-control design.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec012">
<title>HLA DQB1 polymorphisms and the risk for GBS</title>
<sec id="sec013">
<title>HLA-DQB1*020x polymorphism</title>
<p>Data reporting on the HLA-DQB1*020x polymorphism are described in six case-control studies [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Three studies were conducted in Asian populations [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>], two studies were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>], and one study was conducted in an Arabic population [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>]. The meta-analysis demonstrated no significant association between the HLA-DQB1*020x polymorphism and the risk for GBS (OR: 0.86, 95% CI: 0.66–1.12; <italic>P</italic> = 0.27) (<xref rid="pone.0131374.g002" ref-type="fig">Fig 2A</xref>). There was no evidence of significant heterogeneity between studies (<italic>P</italic> = 0.55, <italic>I</italic><sup><italic>2</italic></sup> = 0%).</p>
<p>Subgroup analyses stratified by ethnicity (Asian and Caucasian) demonstrated no significant association between the HLA-DQB1*020x polymorphism and the risk for GBS in Asians (OR: 0.99, 95% CI: 0.68–1.61; <italic>P</italic> = 0.97) or Caucasians (OR: 0.85, 95% CI: 0.61–1.61; <italic>P</italic> = 0.36) (<xref rid="pone.0131374.g002" ref-type="fig">Fig 2B</xref>).</p>
<fig id="pone.0131374.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Association between the HLA-DQB1*020x polymorphism and the risk for GBS.</title>
<p>(<bold>A</bold>) Six studies describe the association between the HLA-DQB1*020x polymorphism and the risk for GBS in a mixed Asian, Caucasian, and Arabic population. (<bold>B</bold>) Subgroup analysis examining the relationship between HLA-DQB1*020x and GBS risk in Caucasian (<italic>top</italic>) and Asian (<italic>bottom</italic>) populations.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g002" position="float" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>HLA-DQB1*030x polymorphism</title>
<p>Data reporting on the HLA-DQB1*030x polymorphism are described in eight case-control studies [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Five studies were conducted in Asian populations [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>], two studies were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>], and one study was conducted in an Arabic population [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>]. The meta-analysis demonstrated no significant association between the HLA-DQB1*030x polymorphism and the risk for GBS (OR: 0.89, 95% CI: 0.64–1.25; <italic>P</italic> = 0.51) (<xref rid="pone.0131374.g003" ref-type="fig">Fig 3A</xref>). However, there was evidence of significant heterogeneity between studies (<italic>P</italic> = 0.03, <italic>I</italic><sup><italic>2</italic></sup> = 54%).</p>
<fig id="pone.0131374.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Association between the HLA-DQB1*030x polymorphism and the risk for GBS.</title>
<p>(<bold>A</bold>) Eight studies describe the association between the HLA-DQB1*030x polymorphism and the risk for GBS in a mixed Asian, Caucasian, and Arabic population. (<bold>B</bold>) Subgroup analysis examining the relationship between HLA-DQB1*030x and GBS risk in Caucasian (<italic>top</italic>) and Asian (<italic>bottom</italic>) populations.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g003" position="float" xlink:type="simple"/>
</fig>
<p>Subgroup analyses stratified by ethnicity (Asian or Caucasian) demonstrated no significant association between the HLA-DQB1*030x polymorphism and the risk for GBS in Asians (OR: 0.76, 95% CI: 0.73–1.13; <italic>P</italic> = 0.07) or Caucasians (OR: 1.14, 95% CI: 0.81–1.60; <italic>P</italic> = 0.46) (<xref rid="pone.0131374.g003" ref-type="fig">Fig 3B</xref>). There was no evidence of significant heterogeneity between studies within the Asian (<italic>P</italic> = 0.10, <italic>I</italic><sup><italic>2</italic></sup> = 48%) or Caucasian (<italic>P</italic> = 0.22, <italic>I</italic><sup><italic>2</italic></sup> = 34%) subgroups.</p>
</sec>
<sec id="sec015">
<title>HLA-DQB1*040x polymorphism</title>
<p>Data reporting on the HLA-DQB1*040x polymorphism are described in seven case-control studies [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Five studies were conducted in Asian populations [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>], and two studies were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>]. The meta-analysis demonstrated no significant association between the HLA-DQB1*040x polymorphism and the risk for GBS (OR: 0.98, 95% CI: 0.69–1.41; <italic>P</italic> = 0.93) (<xref rid="pone.0131374.g004" ref-type="fig">Fig 4A</xref>). There was no evidence of significant heterogeneity between studies (<italic>P</italic> = 0.10, <italic>I</italic><sup><italic>2</italic></sup> = 43%).</p>
<fig id="pone.0131374.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Association between the HLA-DQB1*040x polymorphism and the risk for GBS.</title>
<p>(<bold>A</bold>) Seven studies describe the association between the HLA-DQB1*040x polymorphism and the risk for GBS in a mixed Asian and Caucasian population. (<bold>B</bold>) Subgroup analysis examining the relationship between HLA-DQB1*040x and GBS risk in Caucasian (<italic>top</italic>) and Asian (<italic>bottom</italic>) populations.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g004" position="float" xlink:type="simple"/>
</fig>
<p>Subgroup analyses stratified by ethnicity demonstrated no significant association between the HLA-DQB1*040x polymorphism and the risk for GBS in Asians (OR: 0.98, 95% CI: 0.69–1.41; <italic>P</italic> = 0.93) or Caucasians (OR: 0.94, 95% CI: 0.42–2.11; <italic>P</italic> = 0.88) (<xref rid="pone.0131374.g004" ref-type="fig">Fig 4B</xref>). However, there was evidence of significant heterogeneity between studies in the Asian subgroup (<italic>P</italic> = 0.04, <italic>I</italic><sup><italic>2</italic></sup> = 60%).</p>
</sec>
<sec id="sec016">
<title>HLA-DQB1*050x polymorphism</title>
<p>Data reporting on the HLA-DQB1*050x polymorphism are described in nine case-control studies [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Five studies were conducted in Asian populations [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>], three studies were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0131374.ref027" ref-type="bibr">27</xref>], and one study was conducted in an Arabic population [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>]. The meta-analysis demonstrated no significant association between the HLA-DQB1*050x polymorphism and the risk for GBS (OR: 1.02, 95% CI: 0.82–1.27; <italic>P</italic> = 0.87) (<xref rid="pone.0131374.g005" ref-type="fig">Fig 5A</xref>). There was no evidence of significant heterogeneity between studies (<italic>P</italic> = 0.60, <italic>I</italic><sup><italic>2</italic></sup> = 0%).</p>
<fig id="pone.0131374.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Association between the HLA-DQB1*050x polymorphism and the risk for GBS.</title>
<p>(<bold>A</bold>) Nine studies describe the association between the HLA-DQB1*050x polymorphism and the risk for GBS in a mixed Asian, Caucasian, and Arabic population. (<bold>B</bold>) Subgroup analysis examining the relationship between HLA-DQB1*050x and GBS risk in Caucasian (<italic>top</italic>) and Asian (<italic>bottom</italic>) populations.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g005" position="float" xlink:type="simple"/>
</fig>
<p>Subgroup analyses stratified by ethnicity (Asian and Caucasian) demonstrated no significant association between the HLA-DQB1*050x polymorphism and the risk for GBS in Asians (OR: 0.97, 95% CI: 0.69–1.37; <italic>P</italic> = 0.86) or Caucasians (OR: 1.11, 95% CI: 0.83–1.48; <italic>P</italic> = 0.49) (<xref rid="pone.0131374.g005" ref-type="fig">Fig 5B</xref>).</p>
</sec>
<sec id="sec017">
<title>HLA-DQB1*060x polymorphism</title>
<p>Data reporting on the HLA-DQB1*060x polymorphism are described in nine case-control studies [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>]. Five studies were conducted in Asian populations [<xref rid="pone.0131374.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0131374.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0131374.ref028" ref-type="bibr">28</xref>], three studies were conducted in Caucasian populations [<xref rid="pone.0131374.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0131374.ref027" ref-type="bibr">27</xref>], and one study was conducted in an Arabic population [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>]. The meta-analysis demonstrated no significant association between the HLA-DQB1*060x polymorphism and the risk for GBS (OR: 1.48, 95% CI: 0.96–2.29; <italic>P</italic> = 0.08) (<xref rid="pone.0131374.g006" ref-type="fig">Fig 6A</xref>). There was proof of significant heterogeneity between studies (<italic>P</italic> &lt; 0.0001, <italic>I</italic><sup><italic>2</italic></sup> = 77%). The heterogeneity was due largely to the study by Sinha <italic>et al</italic>., which showed a significant increase in the frequency of the HLA-DQB1*060x allele in GBS patients compared to healthy controls [<xref rid="pone.0131374.ref017" ref-type="bibr">17</xref>].</p>
<fig id="pone.0131374.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Association between the HLA-DQB1*060x polymorphism and the risk for GBS.</title>
<p>(<bold>A</bold>) Nine studies describe the association between the HLA-DQB1*060x polymorphism and the risk for GBS in a mixed Asian, Caucasian, and Arabic population. (<bold>B</bold>) Subgroup analysis examining the relationship between HLA-DQB1*060x and GBS risk in Caucasian (<italic>top</italic>) and Asian (<italic>bottom</italic>) populations.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g006" position="float" xlink:type="simple"/>
</fig>
<p>Subgroup analyses stratified by ethnicity (Asian and Caucasian) demonstrated no significant association between the HLA-DQB1*060x polymorphism and the risk for GBS in Asians (OR: 1.78, 95% CI: 0.74–4.28, <italic>P</italic> = 0.20) or Caucasians (OR: 1.12, 95% CI: 0.85–1.47, <italic>P</italic> = 0.41) (<xref rid="pone.0131374.g006" ref-type="fig">Fig 6B</xref>).</p>
</sec>
<sec id="sec018">
<title>Publication bias</title>
<p>Visual inspection of Funnel plots revealed no significant publication bias for the HLA-DQB1 allele studies (<xref rid="pone.0131374.g007" ref-type="fig">Fig 7</xref>).</p>
<fig id="pone.0131374.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0131374.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Assessment of publication bias for the HLA-DQB1*020x, *030x, *040x, *050x, and *060x polymorphisms.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0131374.g007" position="float" xlink:type="simple"/>
</fig>
</sec>
</sec>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Discussion</title>
<p>In this study, we investigated the associations between the HLA-DQB1 allele polymorphisms and the risk for GBS. The meta-analysis demonstrated no significant association between any of the HLA-DQB1 alleles and the risk for GBS in a mixed population of Asian and Caucasian patients. There were two associations that approached significance: HLA-DQB1*030x in Asian patients (<italic>P</italic> = 0.07; OR: 0.76, 95% CI: 0.57–1.03) and HLA-DQB1*060x in all patients (<italic>P =</italic> 0.08; OR: 1.48, 95% CI: 0.96–2.29). The heterogeneity observed between studies for the HLA-DQB1*030x polymorphism reflects the mixture of Asian and Caucasian populations, given that this polymorphism is a potential risk factor for Asians but not Caucasians. In contrast, HLA-DQB1*060x only approached significance when all of the studies were utilized, suggesting that its potential association with GBS risk spans ethnic lines. Additional studies are required to determine whether these associations will become significant.</p>
<p>Given that the prevalence of GBS subtypes varies regionally [<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>], it would be plausible to speculate that this variation is attributable to differences in host immune background and/or local <italic>C</italic>. <italic>jejuni</italic> strains. Our analysis tends to suggest that HLA-DQB1*030x might be one such allele that could contribute to regional variation in GBS. Further studies are warranted to understand how HLA-DQB1*030 and <italic>C</italic>. <italic>jejuni</italic> might interact in Asian populations to affect the risk for GBS.</p>
<p>While we did not identify a significant association between HLA-DQB1 alleles and the risk for GBS, other host factors may still be contributing to GBS risk. The leading hypothesis is that GBS-susceptible hosts produce antibodies targeting bacterial ganglioside-like lipooligosaccharides, which cross-react with gangliosides, leading to axonal degeneration [<xref rid="pone.0131374.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0131374.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0131374.ref030" ref-type="bibr">30</xref>]. Host ethnicity may qualitatively affect the way that <italic>C</italic>. <italic>jejuni</italic> strains interact with the immune system to cause different subtypes of GBS [<xref rid="pone.0131374.ref031" ref-type="bibr">31</xref>]. Immunomodulatory host factors may also partially determine the clinical heterogeneity of GBS [<xref rid="pone.0131374.ref032" ref-type="bibr">32</xref>]. Wu <italic>et al</italic>. have conducted a large meta-analysis to assess the contribution of polymorphisms in tumor necrosis factor (TNF)α, FCγrIII, and CD1 to GBS susceptibility. They identified a significant association between the TNFα-308 G/A polymorphism and the risk for GBS, particularly in Asian populations [<xref rid="pone.0131374.ref003" ref-type="bibr">3</xref>]. Thus, polymorphisms in effector molecules likely contribute to GBS susceptibility.</p>
<p>There are also strong ethnic associations between HLA-DR alleles and GBS risk. In Mexican patients, the HLA-DR3 polymorphism has been associated with an increased risk for GBS [<xref rid="pone.0131374.ref033" ref-type="bibr">33</xref>]. In addition, the HLA-DRB1*0701 polymorphism was identified as a novel genetic risk factor for the development of GBS with preceding infection [<xref rid="pone.0131374.ref014" ref-type="bibr">14</xref>]. In Japan, a significantly higher frequency of the HLA-DRBl*0803 polymorphism was found in <italic>C</italic>. <italic>jejuni</italic>-positive GBS patients, compared to controls [<xref rid="pone.0131374.ref026" ref-type="bibr">26</xref>]. Finally, in Dutch GBS patients who needed mechanical ventilation, the frequency of the HLA-DRB1*01 polymorphism was significantly greater than that of controls and patients with less severe disease [<xref rid="pone.0131374.ref024" ref-type="bibr">24</xref>].</p>
<p>There are several limitations to our study. We only investigated the link between HLA-DQB1 alleles and the risk for GBS. Other HLA alleles were not investigated but may contribute to GBS risk and should be evaluated. We were also limited by the relatively small sample size. There is evidence that gender-related factors may influence the interaction between HLA-DR2 polymorphisms and patients with GBS and chronic inflammatory demyelinating polyradiculoneuropathy (CDIP). More female CIDP patients have been reported to be homozygous for HLA-DR2 than male CIDP patients or controls. We were unable to examine the effects of gender in our analysis. Large rigorously conducted studies are needed to elucidate whether there is an association between HLA-DQB1 polymorphisms and the risk for GBS.</p>
<p>In conclusion, our meta-analysis indicated no significant associations between HLA-DQB1 alleles and the risk for GBS in mixed Asian and Caucasian populations. Additional rigorous studies that enroll a large number of patients investigating multiple loci are required to continue investigations into the association between HLA-DQB1 polymorphisms and the risk for GBS.</p>
</sec>
<sec id="sec020">
<title>Supporting Information</title>
<supplementary-material id="pone.0131374.s001" xlink:href="info:doi/10.1371/journal.pone.0131374.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>Meta-analysis on Genetic Association Studies Checklist | Plos ONE.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0131374.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pithadia</surname> <given-names>AB</given-names></name>, <name name-style="western"><surname>Kakadia</surname> <given-names>N</given-names></name>. <article-title>Guillain-Barré syndrome (GBS)</article-title>. <source>Pharmacol Rep</source>. <year>2010</year>; <volume>61</volume>: <fpage>220</fpage>–<lpage>232</lpage>.</mixed-citation></ref>
<ref id="pone.0131374.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nyati</surname> <given-names>KK</given-names></name>, <name name-style="western"><surname>Nyati</surname> <given-names>R</given-names></name>. <article-title>Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: An update</article-title>. <source>Biomed Res Int</source>. <year>2013</year>; <fpage>852195</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2013/852195" xlink:type="simple">10.1155/2013/852195</ext-link></comment> <object-id pub-id-type="pmid">24000328</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>B</given-names></name>. <article-title>The effect of TNA-alpha, FCγR and CD1 polymorphisms on Guillain-Barre Syndrome risk: Evidences from a meta-analysis</article-title>. <source>J Neuroimmunol</source> <year>2012</year>; <volume>243</volume>: <fpage>18</fpage>–<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jneuroim.2011.12.003" xlink:type="simple">10.1016/j.jneuroim.2011.12.003</ext-link></comment> <object-id pub-id-type="pmid">22236374</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Repiska</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Shawkatova</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Bohmer</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hatzibougias</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sisovsky</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Danihel</surname> <given-names>Ľ</given-names></name>. <article-title>Gestational choriocarcinoma analyzed by polymerase chain reaction amplification of polymorphic VNTR and human leukocyte antigen regions</article-title>. <source>Int J Gynaecol Obstet</source>. <year>2010</year>; <volume>110</volume>: <fpage>152</fpage>–<lpage>154</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijgo.2010.03.019" xlink:type="simple">10.1016/j.ijgo.2010.03.019</ext-link></comment> <object-id pub-id-type="pmid">20435306</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andreoni</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bondani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nardo</surname> <given-names>L</given-names></name>. <article-title>Time-resolved FRET method for typing polymorphic alleles of the human leukocyte antigen system by using a single DNA probe</article-title>. <source>Photochem Photobiol Sci</source>. <year>2009</year>; <volume>8</volume>: <fpage>1202</fpage>–<lpage>1206</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1039/b906043j" xlink:type="simple">10.1039/b906043j</ext-link></comment> <object-id pub-id-type="pmid">19639124</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schroeder</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Reck</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hoeft</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Stuber</surname> <given-names>F</given-names></name>. <article-title>Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis</article-title>. <source>Crit Care Med</source>. <year>1999</year>; <volume>27</volume>: <fpage>1265</fpage>–<lpage>1270</lpage>. <object-id pub-id-type="pmid">10446818</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Connor</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Rosa</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>Muir</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schatz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Silverstein</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1996</year>; <volume>81</volume>: <fpage>2559</fpage>–<lpage>2563</lpage>. <object-id pub-id-type="pmid">8675578</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huh</surname> <given-names>KB</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>HR</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. <article-title>Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseases</article-title>. <source>Korean J Intern Med</source>. <year>1986</year>; <volume>1</volume>: <fpage>243</fpage>–<lpage>248</lpage>. <object-id pub-id-type="pmid">3154621</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hillert</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Osterman</surname> <given-names>PO</given-names></name>, <name name-style="western"><surname>Olerup</surname> <given-names>OE</given-names></name>. <article-title>No association with HLA-DR,-DQ, or–DP alleles in Guillain-Barre Syndrome</article-title>. <source>J Neuroimmunol</source>. <year>1991</year>; <volume>31</volume>: <fpage>67</fpage>–<lpage>72</lpage>. <object-id pub-id-type="pmid">1984036</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luppi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Licata</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Haluszczak</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rudert</surname> <given-names>WA</given-names></name>, <name name-style="western"><surname>Trucco</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>McGowan</surname> <given-names>FX</given-names> <suffix>Jr</suffix></name>, <etal>et al</etal>. <article-title>Analysis of TCR Vbeta repertoire and cytokine gene expression in patients with idiopathic dilated cardiomyopathy</article-title>. <source>J Autoimmun</source>. <year>2001</year>; <volume>16</volume>: <fpage>3</fpage>–<lpage>13</lpage>. <object-id pub-id-type="pmid">11221991</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klein</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sato</surname> <given-names>A</given-names></name>. <article-title>The HLA system. Second of two parts</article-title>. <source>N Engl J Med</source>. <year>2000</year>; <volume>343</volume>: <fpage>782</fpage>–<lpage>786</lpage>. <object-id pub-id-type="pmid">10984567</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Magira</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Papaioakim</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nachamkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Asbury</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Ho</surname> <given-names>TW</given-names></name>, <etal>et al</etal>. <article-title>Differential distribution of HLA-DQB/DRB epitopes in the two forms of Guillain-Barre Syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): Identification of DQB epitopes associated with susceptibility to and protection from AIDP</article-title>. <source>J Immunol</source>. <year>2003</year>; <volume>170</volume>: <fpage>3074</fpage>–<lpage>3080</lpage>. <object-id pub-id-type="pmid">12626563</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rees</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Vaughan</surname> <given-names>RW</given-names></name>, <name name-style="western"><surname>Kondeatis</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hughes</surname> <given-names>RA</given-names></name>. <article-title>HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection</article-title>. <source>J Neuroimmunol</source>. <year>1995</year>; <volume>62</volume>: <fpage>53</fpage>–<lpage>57</lpage>. <object-id pub-id-type="pmid">7499492</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinha</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Prasad</surname> <given-names>KN</given-names></name>, <name name-style="western"><surname>Jain</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Nyati</surname> <given-names>KK</given-names></name>, <name name-style="western"><surname>Pradhan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Agrawal</surname> <given-names>S</given-names></name>. <article-title>Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barré syndrome</article-title>. <source>Acta Neurol Scand</source>. <year>2010</year>; <volume>122</volume>: <fpage>21</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-0404.2009.01229.x" xlink:type="simple">10.1111/j.1600-0404.2009.01229.x</ext-link></comment> <object-id pub-id-type="pmid">20105138</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Eastwood</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Olkin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Stroup</surname> <given-names>DF</given-names></name>. <article-title>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses</article-title>. <source>Lancet</source>. <year>1999</year>; <volume>354</volume>: <fpage>1896</fpage>–<lpage>1900</lpage>. <object-id pub-id-type="pmid">10584742</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bero</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Rennie</surname> <given-names>D</given-names></name>. <collab xlink:type="simple">The Cochrane Collaboration</collab>. <article-title>Preparing, maintaining, and disseminating systematic reviews of the effects of health care</article-title>. <source>JAMA</source>. <year>1995</year>; <volume>274</volume>: <fpage>1935</fpage>–<lpage>1938</lpage>. <object-id pub-id-type="pmid">8568988</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fekih-Mrissa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Mrad</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Riahi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sayeh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zaouali</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gritli</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Association of HLA-DR/DQ polymorphisms with Guillain-Barre Syndrome in Tunisian patients</article-title>. <source>Clin Neurol Neurosurg</source>. <year>2014</year>; <volume>121</volume>:<fpage>19</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clineuro.2014.03.014" xlink:type="simple">10.1016/j.clineuro.2014.03.014</ext-link></comment> <object-id pub-id-type="pmid">24793468</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>; <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lau</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ioannidis</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Schmid</surname> <given-names>CH</given-names></name>. <article-title>Quantitative synthesis in systematic reviews</article-title>. <source>Ann Intern Med</source> <year>1997</year>; <volume>127</volume>: <fpage>820</fpage>–<lpage>826</lpage>. <object-id pub-id-type="pmid">9382404</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>. <year>2003</year>; <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>. <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname> <given-names>W</given-names></name>. <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source>. <year>1959</year>; <volume>22</volume>: <fpage>719</fpage>–<lpage>748</lpage>. <object-id pub-id-type="pmid">13655060</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>; <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey</surname> <given-names>Smith G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>; <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage> <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geleijns</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Schreuder</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>BC</given-names></name>, <name name-style="western"><surname>Sintnicolaas</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>van Koningsveld</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Meulstee</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome</article-title>. <source>Neurology</source>. <year>2005</year>; <volume>64</volume>: <fpage>44</fpage>–<lpage>49</lpage>. <object-id pub-id-type="pmid">15642902</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>. <article-title>HLA alleles in patients with Guillain-Barré syndrome</article-title>. <source>Chin Med J</source> <year>2000</year>; <volume>113</volume>: <fpage>429</fpage>–<lpage>432</lpage>. <object-id pub-id-type="pmid">11776098</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Nishimura</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mine</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kuroki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nukina</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ohta</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome</article-title>. <source>Neurology</source> <year>1998</year>; <volume>51</volume>: <fpage>379</fpage>–<lpage>384</lpage>. <object-id pub-id-type="pmid">9710006</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCombe</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Csurhes</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Greer</surname> <given-names>JM</given-names></name>. <article-title>Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)</article-title>. <source>J Neuroimmunol</source>. <year>2006</year>; <volume>180</volume>: <fpage>172</fpage>–<lpage>177</lpage>. <object-id pub-id-type="pmid">16935351</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yuki</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kashiwase</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tadokoro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Juji</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hirata</surname> <given-names>K</given-names></name>. <article-title>Guillain-Barre Syndrome and Fisher’s Syndromes subsequent to <italic>Campylobacter jejuni</italic> enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies</article-title>. <source>J Neuroimmunol</source>. <year>1998</year>; <volume>88</volume>:<fpage>62</fpage>–<lpage>66</lpage>. <object-id pub-id-type="pmid">9688325</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geleijns</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Roos</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Houwing-Duistermaat</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>van Rijs</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Tio-Gillen</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Laman</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome</article-title>. <source>J Immunol</source>. <year>2006</year>; <volume>177</volume>: <fpage>4211</fpage>–<lpage>4217</lpage>. <object-id pub-id-type="pmid">16951387</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kimoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Koga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Odaka</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hirata</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies</article-title>. <source>Neurology</source>. <year>2006</year>; <volume>67</volume>: <fpage>1837</fpage>–<lpage>1843</lpage>. <object-id pub-id-type="pmid">17130419</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ho</surname> <given-names>TW</given-names></name>, <name name-style="western"><surname>Mishu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Cornblath</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Griffin</surname> <given-names>JW</given-names></name>, <etal>et al</etal>. <article-title>Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies</article-title>. <source>Brain</source> <year>1995</year>; <volume>118</volume>: <fpage>597</fpage>–<lpage>605</lpage> <object-id pub-id-type="pmid">7600081</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Enders</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Karch</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Toyka</surname> <given-names>KV</given-names></name>, <name name-style="western"><surname>Michels</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zielasek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pette</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders</article-title>. <source>Ann Neurol</source>. <year>1993</year>; <volume>34</volume>: <fpage>136</fpage>–<lpage>144</lpage>. <object-id pub-id-type="pmid">8338338</object-id></mixed-citation></ref>
<ref id="pone.0131374.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gorodezky</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Varela</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Castro-Escobar</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Chávez-Negrete</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Escobar-Gutiérrez</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Martínez-Mata</surname> <given-names>J</given-names></name>. <article-title>HLA-DR antigens in Mexican patients with Guillain-Barré syndrome</article-title>. <source>J Neuroimmunol</source>. <year>1983</year>; <volume>4</volume>: <fpage>1</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">6401765</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>